Consultation record

Submissions accepted in part — page 2

Part of the submission is accepted and part is not. The secretariat response states which part is which and on what ground the remainder was declined.

Submissions

377 documents · page 2 of 13

Table 1. Submissions with this disposition, on this page.

Reference	Consultation	Respondent	Point raised
DRAFT-FUNDING-POLI/002	Draft funding and sponsorship policy	Dr Liesbeth Delacroix-Njoku	A party criticised in an assessment should have a right of reply
DRAFT-FUNDING-POLI/001	Draft funding and sponsorship policy	Dr Henrike Jastrzębska	The secretariat answers submissions and is not itself named
DRAFT-FUNDING-POLI/004	Draft funding and sponsorship policy	Dr Eamon Immelmann	The document is unreadable without specialist training
DRAFT-CITATION-POL/001	Draft citation policy	Dr Quentin Whitmarsh-Obi	Point estimates are given without an interval
DRAFT-CITATION-POL/004	Draft citation policy	Dr Hortensia Larsson-Ekwueme	The materiality threshold for a declarable holding is set too high
DRAFT-CITATION-POL/003	Draft citation policy	Dr Ottoline Oppenheimer-Ade	Funding should not be accepted from any party the Institute assesses
DRAFT-PROGRAMME-RE/001	Draft policy: labelling of Institute-constructed programme records	Dr Zebedee Zaleski-Mbeki	A party criticised in an assessment should have a right of reply
DRAFT-PROGRAMME-RE/002	Draft policy: labelling of Institute-constructed programme records	Dr Ottoline Fitzgerald-Nwosu	The secretariat answers submissions and is not itself named
DRAFT-PROGRAMME-RE/003	Draft policy: labelling of Institute-constructed programme records	Dr Wolfram Kaltenbach-Mensah	The document is unreadable without specialist training
DRAFT-ENDOTOXIN-ST/012	Draft standard: bacterial endotoxin testing of peptide presentations	Dr Valentin Castellanos-Reid	Results are reported without an estimate of measurement uncertainty
DRAFT-ENDOTOXIN-ST/011	Draft standard: bacterial endotoxin testing of peptide presentations	Dr Frideswide Nordhagen	A field classified as critical is not one a reading turns on
DRAFT-ENDOTOXIN-ST/008	Draft standard: bacterial endotoxin testing of peptide presentations	Ignatius Erlingsson	References should carry a persistent identifier for every cited source
DRAFT-ENDOTOXIN-ST/009	Draft standard: bacterial endotoxin testing of peptide presentations	Dr Ngozi Zetterlund	Acceptance criteria are expressed in terms specific to one instrument family
DRAFT-ANALYTICAL-S/001	Draft scope of the analytical and methodological standards series	Dr Amara Quaresma	The document is unreadable without specialist training
DRAFT-ANALYTICAL-S/008	Draft scope of the analytical and methodological standards series	Dr Katarzyna Yorkstone	The series scope is drawn widely enough to absorb documents that belong elsewhere
DRAFT-GLP1-OBESITY/005	Draft synthesis: glucagon-like peptide-1 receptor agonists for weight…	Dr Jerome Lavrentiev	The review protocol is described but its registration record is not linked
DRAFT-GLP1-OBESITY/008	Draft synthesis: glucagon-like peptide-1 receptor agonists for weight…	Dr Delphine Ravensworth	References should carry a persistent identifier for every cited source
DRAFT-GLP1-OBESITY/003	Draft synthesis: glucagon-like peptide-1 receptor agonists for weight…	Dr Wolfram Tollemache	The same concern is used to downgrade in two domains
DRAFT-GLP1-OBESITY/014	Draft synthesis: glucagon-like peptide-1 receptor agonists for weight…	Dr Anselm Ashworth-Danquah	Two included studies do not meet the registered eligibility criteria
DRAFT-GLP1-OBESITY/004	Draft synthesis: glucagon-like peptide-1 receptor agonists for weight…	Dr Wojciech Kaltenbach-Mensah	Regulatory assessment documents were not searched
DRAFT-GLP1-OBESITY/001	Draft synthesis: glucagon-like peptide-1 receptor agonists for weight…	Dr Ulysses Bellingham-Ojo	Point estimates are given without an interval
DRAFT-GLP1-OBESITY/007	Draft synthesis: glucagon-like peptide-1 receptor agonists for weight…	Dr Frideswide Grünbaum-Sowande	Subgroup findings are reported that were not registered in the protocol
DRAFT-GLP1-OBESITY/002	Draft synthesis: glucagon-like peptide-1 receptor agonists for weight…	Dr Abimbola Sotomayor-Ekwueme	Patient-reported outcomes are collected by the trials and not reported by the review
DRAFT-LEAN-MASS-SC/002	Draft scoping review: change in lean mass during pharmacologically…	Dr Ottoline Fitzgerald-Nwosu	The review protocol is described but its registration record is not linked
DRAFT-LEAN-MASS-SC/004	Draft scoping review: change in lean mass during pharmacologically…	Dr Dmitri Nordhagen	The same concern is used to downgrade in two domains
DRAFT-GASTROPARESI/008	Draft safety review: delayed gastric emptying and procedural sedation	Dr Thaddeus Isaksen-Balogun industry	A sponsor trial meeting the eligibility criteria was excluded
DRAFT-GASTROPARESI/007	Draft safety review: delayed gastric emptying and procedural sedation	Dr Melisande Kirkpatrick-Ola	Regulatory assessment documents were not searched
DRAFT-GASTROPARESI/013	Draft safety review: delayed gastric emptying and procedural sedation	Dr Anselm Ashworth-Danquah	A surrogate outcome is used as the anchor without validation evidence
DRAFT-GASTROPARESI/003	Draft safety review: delayed gastric emptying and procedural sedation	Dr Eulalia Sonnenberg-Eze	Patient-reported outcomes are collected by the trials and not reported by the review
DRAFT-GASTROPARESI/001	Draft safety review: delayed gastric emptying and procedural sedation	Hortensia Hollingworth	The document is unreadable without specialist training

page 2 of 13